ng-nitroarginine methyl ester has been researched along with Animal Mammary Carcinoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katiyar, SK; Punathil, T; Tollefsbol, TO | 1 |
| Lala, PK; Orucevic, A | 1 |
| Cendan, JC; Copeland, EM; Lind, DS; Pruitt, J; Snowdy, S; Topping, DL | 1 |
| Davel, LE; De Lustig, ES; Eijan, AM; Jasnis, MA; Rozenberg, G; Rueda, HA | 1 |
| Jadeski, LC; Lala, PK | 1 |
5 other study(ies) available for ng-nitroarginine methyl ester and Animal Mammary Carcinoma
| Article | Year |
|---|---|
EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase.
Topics: Animals; Anticarcinogenic Agents; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Mammary Neoplasms, Animal; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitrogen Oxides; Oxadiazoles; Quinoxalines | 2008 |
NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice.
Topics: Adenocarcinoma; Analysis of Variance; Animals; Antineoplastic Agents; Arginine; Capillary Permeability; Combined Modality Therapy; Female; Immunotherapy; Interleukin-2; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Neoplasm Transplantation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pleural Effusion, Malignant; Pulmonary Edema; Statistics, Nonparametric; Tumor Cells, Cultured | 1996 |
Inflammatory mediators stimulate arginine transport and arginine-derived nitric oxide production in a murine breast cancer cell line.
Topics: Animals; Arginine; Biological Transport; Dose-Response Relationship, Drug; Inflammation Mediators; Interferons; Lipopolysaccharides; Mammary Neoplasms, Animal; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Tumor Cells, Cultured | 1996 |
Differential nitric oxide release and sensitivity to injury in different murine mammary tumor cell lines.
Topics: Animals; Cell Line, Tumor; Enzyme Inhibitors; Female; Humans; Interferon-gamma; Lipopolysaccharides; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitroprusside | 1998 |
Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors.
Topics: Animals; Coloring Agents; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Female; Immunohistochemistry; Macrophages; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Platelet Endothelial Cell Adhesion Molecule-1; Tumor Cells, Cultured | 1999 |